@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-X6NNB38B-S
  skos:prefLabel "Anti-Inflammatory Agents, Non-Steroidal"@en, "Anti-inflammatoires non stéroïdiens"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-MG26Q8PT-D
  skos:altLabel "54-21-7 (Sodium Salicylate)"@en, "WIQ1H85SYP"@fr, "WIQ1H85SYP"@en, "Benzoic acid, 2-hydroxy-, monosodium salt"@fr, "Benzoic acid, 2-hydroxy-, monosodium salt"@en, "54-21-7 (Sodium Salicylate)"@fr ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D012980> ;
  skos:inScheme jvr: ;
  mesh:allowableQualifier jvr:-TJHVZCRZ-0, jvr:-G4R176S9-J, jvr:-L6C0XPHT-4, jvr:-D0F21513-5, jvr:-M63HSDM7-1, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-NFTHND7Q-8, jvr:-HQRFT0C6-B, jvr:-THHNVC7V-3, jvr:-BT300B3G-Q, jvr:-NB0XHT3S-N, jvr:-R0ZCQ8X6-J, jvr:-S0CS1X5R-5, jvr:-NHL3D2X0-S, jvr:-FWD2BGQ0-9, jvr:-XV06LPML-W, jvr:-H7K65Q8S-Z, jvr:-Q3979798-W, jvr:-W6SQV79N-S, jvr:-NKM836P1-M, jvr:-T9HQD7ST-J, jvr:-CB30NGKB-3, jvr:-WK5F724J-1, jvr:-R3QWLHRG-V ;
  skos:prefLabel "Salicylate de sodium"@fr, "Sodium Salicylate"@en ;
  mesh:pharmacologicalAction jvr:-X6NNB38B-S, jvr:-KX54L1M6-P ;
  skos:broader jvr:-G5NSQWD5-6 ;
  dc:created "1999-01-01"^^xsd:date ;
  dc:modified "2013-07-08"^^xsd:date ;
  dc:established "1966-01-01"^^xsd:date ;
  skos:definition "A non-steroidal anti-inflammatory agent that is less effective than equal doses of ASPIRIN in relieving pain and reducing fever. However, individuals who are hypersensitive to ASPIRIN may tolerate sodium salicylate. In general, this salicylate produces the same adverse reactions as ASPIRIN, but there is less occult gastrointestinal bleeding. (From AMA Drug Evaluations Annual, 1992, p120)"@en ;
  a skos:Concept, mesh:Descriptor .

jvr:-G5NSQWD5-6
  skos:prefLabel "Acide salicylique"@fr, "Salicylic Acid"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-MG26Q8PT-D .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-KX54L1M6-P
  skos:prefLabel "Inhibiteurs des cyclooxygénases"@fr, "Cyclooxygenase Inhibitors"@en ;
  a mesh:Descriptor, skos:Concept .